# Clinical Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HSK31858 in Healthy Subjects

> **NCT07134465** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Haisco Pharmaceutical Group Co., Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** HSK31858 Tablets and Itraconazole Capsules

## Key facts

- **NCT ID:** NCT07134465
- **Lead sponsor:** Haisco Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-08-11
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07134465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07134465, "Clinical Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HSK31858 in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07134465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*